Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.190
0.00 (0.00%)
Nov 18, 2025, 2:03 PM EST - Market open
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $7.51 million as of November 18, 2025. Its market cap has decreased by -64.64% in one year.
Market Cap
7.51M
Enterprise Value
-6.18M
1-Year Change
-64.64%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $7.51M, a decrease of -60.34%. That is a compound annual growth rate of -23.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 7.51M | -58.00% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |